Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients

British scientists will start testing Merck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics' COVID-19 antiviral pill molnupiravir as a possible treatment for patients hospitalized with COVID-19,

Benzinga

Pharma Stocks Dip As Pfizer, Merck Sustain Unexpected FDA Rejections

Pfizer stock skidded Monday after the Food and Drug Administration rejected its rare-disease drug — leading a smaller decline for similarly jilted Merck.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Testing for fully vaccinated travellers to UK to be scrapped; new vaccine pass rules in France – as it happened

UK transport secretary says testing rules for travellers into country will change from 4am on 11 February; new France rules come into force

The Guardian - UK

Merck Scores Win In Insurance Battle Over Cyberattack - Bloomberg Report

Bloomberg reported that Merck & Co Inc (NYSE: MRK) has won a long-running legal battle to force its insurer to cover the costs of damages caused by the NotPetya' ransomware' attacks.

Benzinga

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

Key Takeaways

Benzinga

Drugs companies sign deal to produce low-cost Covid drug for 105 countries

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.

France 24

Read news from The Economist, FT, and more,
with one subscription

Dozens of firms to make cheap version of Merck COVID pill for poorer nations

Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck Co's COVID-19 pill, under a landmark U.N.-backed deal to give poorer nations wider access to a drug seen as a weapon in fighting the pandemic.

Reuters

France to ease restrictions; Austrian parliament approves mandatory vaccination – as it happened

French PM says from February work from home guidance will be changed and nightclubs reopen; Austria will have Europe’s first universal jabs mandate

The Guardian - UK

Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial

Merck & Co Inc (NYSE: MRK) has

Benzinga

1 … 19 20 21 22

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.